Na + and K + ion imbalances in Alzheimer's disease

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1822, Issue 11, 2012, Pages 1671-1681

  Vitvitsky, Victor M ^a   Garg, Sanjay K ^a,c   Keep, Richard F ^a   Albin, Roger L ^a,b   Banerjee, Ruma ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Education and Clinical Center   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Alzheimer's disease; Amyloid ; Astrocyte; Brain; Potassium; Sodium

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN[25-35]; EXCITATORY AMINO ACID TRANSPORTER; POTASSIUM ION; SODIUM ION;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; ASTROCYTE; AUTOPSY; BRAIN LEVEL; CELL LEVEL; CEREBELLUM; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; FRONTAL CORTEX; HOMEOSTASIS; HUMAN; HUMAN CELL; INTRACELLULAR SPACE; MOUSE; NONHUMAN; PARIETAL CORTEX; PRIORITY JOURNAL;

ALZHEIMER DISEASE; AMINO ACID TRANSPORT SYSTEM X-AG; AMYLOID BETA-PEPTIDES; ANIMALS; ASTROCYTES; BRAIN; EXCITATORY AMINO ACID TRANSPORTER 2; GLUTAMIC ACID; HEK293 CELLS; HUMANS; JURKAT CELLS; MICE; POTASSIUM; SODIUM; SODIUM-POTASSIUM-EXCHANGING ATPASE;

MURINAE;

EID: 84865059345     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2012.07.004     Document Type: Article

References (48)

1. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 2004, 430:631-639.
2. Pike C.J., Cummings B.J., Monzavi R., Cotman C.W. Beta-amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease. Neuroscience 1994, 63:517-531.
3. Butterfield D.A., Drake J., Pocernich C., Castegna A. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. Trends Mol. Med. 2001, 7:548-554.
4. Lauderback C.M., Hackett J.M., Huang F.F., Keller J.N., Szweda L.I., Markesbery W.R., Butterfield D.A. The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42. J. Neurochem. 2001, 78:413-416.
5. Hattori N., Kitagawa K., Higashida T., Yagyu K., Shimohama S., Wataya T., Perry G., Smith M.A., Inagaki C. CI-ATPase and Na+/K(+)-ATPase activities in Alzheimer's disease brains. Neurosci. Lett. 1998, 254:141-144.
6. Dickey C.A., Gordon M.N., Wilcock D.M., Herber D.L., Freeman M.J., Morgan D. Dysregulation of Na+/K+ ATPase by amyloid in APP+PS1 transgenic mice. BMC Neurosci. 2005, 6:7.
7. Fuller S., Steele M., Munch G. Activated astroglia during chronic inflammation in Alzheimer's disease-Do they neglect their neurosupportive roles?. Mutat. Res. 2010, 690:40-49.
8. Chvatal A., Anderova M., Neprasova H., Prajerova I., Benesova J., Butenko O., Verkhratsky A. Pathological potential of astroglia. Physiol. Res. 2008, 57(Suppl. 3):S101-S110.
9. Meister A., Anderson M.E. Glutathione. Annu. Rev. Biochem. 1983, 52:711-760.
10. McBean G.J. Cerebral cystine uptake: a tale of two transporters. Trends Pharmacol. Sci. 2002, 23:299-302.
11. Banerjee R., Vitvitsky V., Garg S.K. The undertow of sulfur metabolism on glutamatergic neurotransmission. Trends Biochem. Sci. 2008, 33:413-419.
12. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 2001, 65:1-105.
13. Parpura-Gill A., Beitz D., Uemura E. The inhibitory effects of beta-amyloid on glutamate and glucose uptakes by cultured astrocytes. Brain Res. 1997, 754:65-71.
14. +-dependent glutamate uptake in rat hippocampal astrocyte cultures. J. Neurochem. 1996, 67:277-286.
15. Garg S.K., Vitvitsky V., Albin R., Banerjee R. Astrocytic redox remodeling by amyloid beta peptide. Antioxid. Redox Signal. 2011, 14:2385-2397.
16. Amedee T., Robert A., Coles J.A. Potassium homeostasis and glial energy metabolism. Glia 1997, 21:46-55.
17. Alvarez-Maubecin V., Garcia-Hernandez F., Williams J.T., Van Bockstaele E.J. Functional coupling between neurons and glia. J. Neurosci. 2000, 20:4091-4098.
18. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 1994, 77:817-827.
19. Anonymous Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol. Aging 1997, 18:S1-S2.
20. Morris J.C. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993, 43:2412-2414.
21. Fagan A.M., Mintun M.A., Mach R.H., Lee S.Y., Dence C.S., Shah A.R., LaRossa G.N., Spinner M.L., Klunk W.E., Mathis C.A., DeKosky S.T., Morris J.C., Holtzman D.M. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann. Neurol. 2006, 59:512-519.
22. Garg S.K., Banerjee R., Kipnis J. Neuroprotective immunity: T cell-derived glutamate endows astrocytes with a neuroprotective phenotype. J. Immunol. 2008, 180:3866-3873.
23. Garg S.K., Kipnis J., Banerjee R. IFN-gamma and IL-4 differentially shape metabolic responses and neuroprotective phenotype of astrocytes. J. Neurochem. 2009, 108:1155-1166.
24. Pike C.J., Burdick D., Walencewicz A.J., Glabe C.G., Cotman C.W. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 1993, 13:1676-1687.
25. Garg S.K., Yan Z., Vitvitsky V., Banerjee R. Analysis of sulfur-containing metabolites involved in redox and methionine metabolism. Methods in Redox Signaling 2010, 7-11. Mary Ann Liebert, New Rochelle. D.K. Das (Ed.).
26. Garg S., Vitvitsky V., Gendelman H.E., Banerjee R. Monocyte differentiation, activation, and mycobacterial killing are linked to transsulfuration-dependent redox metabolism. J. Biol. Chem. 2006, 281:38712-38720.
27. Sykova E., Vorisek I., Antonova T., Mazel T., Meyer-Luehmann M., Jucker M., Hajek M., Ort M., Bures J. Changes in extracellular space size and geometry in APP23 transgenic mice: a model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:479-484.
28. Tilleux S., Hermans E. Neuroinflammation and regulation of glial glutamate uptake in neurological disorders. J. Neurosci. Res. 2007, 85:2059-2070.
29. Ernst T., Chang L., Melchor R., Mehringer C.M. Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy. Radiology 1997, 203:829-836.
30. Rupsingh R., Borrie M., Smith M., Wells J.L., Bartha R. Reduced hippocampal glutamate in Alzheimer disease. Neurobiol. Aging 2011, 32:802-810.
31. Mellon E.A., Pilkinton D.T., Clark C.M., Elliott M.A., Witschey W.R., Borthakur A., Reddy R. Sodium MR imaging detection of mild Alzheimer disease: preliminary study. AJNR Am. J. Neuroradiol. 2009, 30:978-984.
32. Perry T.L., Hansen S., Berry K., Mok C., Lesk D. Free amino acids and related compounds in biopsies of human brain. J. Neurochem. 1971, 18:521-528.
33. Perry T.L., Hansen S., Gandham S.S. Postmortem changes of amino compounds in human and rat brain. J. Neurochem. 1981, 36:406-410.
34. Kaneko I., Morimoto K., Kubo T. Drastic neuronal loss in vivo by beta-amyloid racemized at Ser(26) residue: conversion of non-toxic [D-Ser(26)]beta-amyloid 1-40 to toxic and proteinase-resistant fragments. Neuroscience 2001, 104:1003-1011.
35. Kubo T., Nishimura S., Kumagae Y., Kaneko I. In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients. J. Neurosci. Res. 2002, 70:474-483.
36. Terranova J.P., Kan J.P., Storme J.J., Perreaut P., Le Fur G., Soubrie P. Administration of amyloid beta-peptides in the rat medial septum causes memory deficits: reversal by SR 57746A, a non-peptide neurotrophic compound. Neurosci. Lett. 1996, 213:79-82.
37. Allaman I., Gavillet M., Belanger M., Laroche T., Viertl D., Lashuel H.A., Magistretti P.J. Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability. J. Neurosci. 2010, 30:3326-3338.
38. Kaminsky Y.G., Marlatt M.W., Smith M.A., Kosenko E.A. Subcellular and metabolic examination of amyloid-beta peptides in Alzheimer disease pathogenesis: evidence for Abeta(25-35). Exp. Neurol. 2010, 221:26-37.
39. Chen X., Zhang J., Chen C. Endocannabinoid 2-arachidonoylglycerol protects neurons against beta-amyloid insults. Neuroscience 2011, 178:159-168.
40. Chiu W.T., Shen S.C., Yang L.Y., Chow J.M., Wu C.Y., Chen Y.C. Inhibition of HSP90-dependent telomerase activity in amyloid beta-induced apoptosis of cerebral endothelial cells. J. Cell. Physiol. 2011, 226:2041-2051.
41. Zussy C., Brureau A., Delair B., Marchal S., Keller E., Ixart G., Naert G., Meunier J., Chevallier N., Maurice T., Givalois L. Time-course and regional analyses of the physiopathological changes induced after cerebral injection of an amyloid beta fragment in rats. Am. J. Pathol. 2011, 179:315-334.
42. Glabe C.G., Kayed R. Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis. Neurology 2006, 66:S74-S78.
43. Wilcock D.M., Vitek M.P., Colton C.A. Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer's disease. Neuroscience 2009, 159:1055-1069.
44. Supnet C., Bezprozvanny I. The dysregulation of intracellular calcium in Alzheimer disease. Cell Calcium 2010, 47:183-189.
45. Bonda D.J., Lee H.G., Blair J.A., Zhu X., Perry G., Smith M.A. Role of metal dyshomeostasis in Alzheimer's disease. Metallomics 2011, 3:267-270.
46. 2+ signals and neuronal death in brain ischemia. Stroke 2007, 38:674-676.
47. Lauritzen M., Dreier J.P., Fabricius M., Hartings J.A., Graf R., Strong A.J. Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury. J. Cereb. Blood Flow Metab. 2011, 31:17-35.
48. Santos S.F., Pierrot N., Octave J.N. Network excitability dysfunction in Alzheimer's disease: insights from in vitro and in vivo models. Rev. Neurosci. 2010, 21:153-171.